Axel Schambach1, Christian J Buchholz2, Raul Torres-Ruiz3

  • 1Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; REBIRTH Research Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany; German Center for Infection Research, partner site Hannover-Braunschweig, Germany.

Lancet (London, England)
|November 25, 2023
PubMed
まとめ

ゲノム編集は遺伝子治療を進めて 遺伝疾患や癌の治療選択肢を広げています このレビューは,将来の患者ケアにおける新しい可能性,安全性,倫理的検討を考察します.